Protalix Biotherapeutics Inc (NYSE American:PLX)

1.23
Delayed Data
As of Aug 12
 +0.005 / +0.41%
Today’s Change
0.70
Today|||52-Week Range
2.00
+47.89%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close1.23
Today’s open1.22
Day’s range1.22 - 1.23
Volume99,318
Average volume (3 months)2,644,636
Market cap$57.7M
Data as of 3:59pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)-179.22%
Earnings growth (this year)+11.29%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-39.03%
P/E ratioNM
Price/Sales0.96
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ASLNAslan Pharmaceutical...+0.16+22.91%
SYRSSyros Pharmaceutical...+0.03+2.70%
MDNAMedicenna Therapeuti...+0.07+7.00%
CBIOCatalyst Biosciences...+0.06+3.23%
Data as of 4:00pm ET, 08/12/2022

Financials

Last reporting dateAugust 15, 2022
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$38.4M
Annual profit (last year)-$27.6M
Net profit margin-71.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Hackensack, New Jersey

Forecasts